Bill
HR 5671
Overview: HR 5671, also known as the Colorectal Cancer Payment Fairness Act, was introduced in the House on September 30, 2025.Purpose and Intent: The primary goal of this bill is
Overview: HR 5671, also known as the Colorectal Cancer Payment Fairness Act, was introduced in the House on September 30, 2025.
Purpose and Intent: The primary goal of this bill is to improve access to colorectal cancer screening and treatment by addressing disparities in insurance coverage and reimbursement.
Key Provisions:
- Requires all private health insurance plans to cover colorectal cancer screening tests, including colonoscopies, without any patient cost-sharing
- Establishes new Medicare and Medicaid reimbursement policies to ensure fair and adequate payment for colorectal cancer screening and treatment services
- Directs the Centers for Disease Control and Prevention (CDC) to launch a public awareness campaign to promote the importance of colorectal cancer screening
Affected Parties and Impacts:
- Individuals, particularly those who are uninsured or underinsured, will have improved access to colorectal cancer screening and early detection
- Healthcare providers, including gastroenterologists and primary care physicians, will benefit from more sustainable reimbursement for colorectal cancer services
- Insurance companies will be required to cover colorectal cancer screening tests without patient cost-sharing
Procedural and Timeline Considerations:
As an introduced bill, HR 5671 will now proceed through the legislative process, including committee hearings, amendments, and potential floor votes in the House. If passed by the House, it would then move to the Senate for further consideration.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
